Zepbound vs Ozempic
Side-by-side on efficacy, form, dosing, side effects, and 2026 cash-pay and insurance pricing.
| Zepbound | Ozempic | |
|---|---|---|
| Active ingredient | Tirzepatide | Semaglutide |
| Form | Injection | Injection |
| Avg weight loss | ~22.5% | ~10–14% |
| Cash price / mo | $299–$499 | $349/mo |
| FDA for obesity | Approved | Off-label |
Not really a fair fight. Zepbound is FDA-approved for weight loss and delivers ~22.5% weight reduction at 15 mg. Ozempic is FDA-approved for type 2 diabetes and delivers ~10–14% off-label for weight loss. If weight loss is your goal, pick Zepbound. If diabetes management is the goal, Ozempic is on-label and cheaper via insurance.
Who wins on what
Different FDA indications, different jobs
Zepbound (tirzepatide) is FDA-approved for chronic weight management and obstructive sleep apnea. Ozempic (semaglutide) is FDA-approved for type 2 diabetes. Comparing them for weight loss means comparing an on-label drug to an off-label one — and the on-label side wins on efficacy, insurance alignment, and price.
If you have type 2 diabetes specifically, the right Lilly comparison is Mounjaro vs Ozempic — same molecules, both on-label for diabetes. For weight management, Zepbound is Lilly's answer and Wegovy is Novo's; cross-comparing Zepbound to Ozempic almost always ends up recommending a switch.
Efficacy gap
Zepbound 15 mg: 22.5% mean weight loss in SURMOUNT-1. Ozempic 2.0 mg (off-label for weight loss): ~10–14% in real-world data.
The ~8–12 percentage point gap reflects three things: tirzepatide's dual mechanism, Zepbound's higher maintenance dose, and the difference between on-label trial populations and off-label real-world cohorts.
If you're currently on Ozempic for weight loss and insurance won't switch you to Wegovy, a conversation about Zepbound is worth having — your prescriber can often make the case based on efficacy gap and on-label alignment.
Cost
Zepbound cash: $349/month via LillyDirect Self Pay — lowest cash price of any top-tier GLP-1. Ozempic cash: ~$999/month retail list, or $499/month via NovoCare for eligible diabetic patients.
Insurance: Ozempic is broadly covered for diabetes (Medicare Part D, commercial, most Medicaid). Zepbound coverage is narrower but expanding; Medicare Part D does not cover Zepbound for weight management.
For uninsured weight-loss-focused patients, Zepbound via LillyDirect is usually the cheapest brand-name path on the market.
Side effects
Both share the GLP-1 class profile. At matched efficacy, tirzepatide tends to show slightly lower peak nausea than semaglutide. At Zepbound's 22.5%-weight-loss doses, side effects are greater in absolute terms than at Ozempic's ~10% doses — there's no free lunch.
Our take
For weight loss, Zepbound is the right drug for most patients. For type 2 diabetes, Ozempic (or Mounjaro) is on-label and broadly covered. If you're paying cash and want the most weight loss per dollar, LillyDirect's $349 Zepbound beats anything else at the brand-name tier.
Frequently asked questions
Is Zepbound better than Ozempic for weight loss?
Yes, meaningfully. Zepbound 15 mg produced 22.5% weight loss in SURMOUNT-1; Ozempic off-label produces about 10–14% in real-world use. Zepbound is on-label for weight management, which also makes insurance coverage easier.
Can I switch from Ozempic to Zepbound?
Yes. Most prescribers stop Ozempic at maintenance dose and start Zepbound at 2.5 mg the following week, titrating as usual. No washout required. Most patients see substantial additional weight loss within 6 months of switching.
Is Zepbound cheaper than Ozempic?
On cash, yes — $349/month via LillyDirect Self Pay versus $999 retail for Ozempic (or $499 via NovoCare for eligible diabetic patients). With insurance, it depends on coverage alignment with your diagnosis.
Which has more side effects?
At matched efficacy, Zepbound tends to produce slightly less peak nausea than Ozempic/Wegovy semaglutide. At their respective maximum doses, Zepbound's side effect burden is larger in absolute terms because it produces more weight loss — there's a dose-response relationship.
Not sure which is right for you? Take the Sherpa Matcher — it accounts for your goals, budget, and insurance in 60 seconds.